The FDA has approved a pill form of the popular GLP-1 weight-loss medication George Frey/Bloomberg via Getty The U.S. Food and Drug Administration has approved the pill form of Wegovy, the weight-loss ...
The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side ...
Flow Neuroscience's FL-100 headset, using transcranial direct current stimulation for at-home depression treatment, has FDA approval for major depressive disorder. Available in the US by late 2026 ...
Bengaluru: The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can ...
The headset uses transcranial direct current stimulation, where electrical energy is directed into the head from the outside. (Representative Image) The US Food and Drug Administration approved Flow ...
Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback